SEP 3·SEC EDGARLow
Hawkins Matthew J. sold $2.1M of WAY
Hawkins Matthew J. (Chief Executive Officer) sold 82,500 shares of Waystar Holding Corp. (WAY) at $25.97 ($2.14M total) on 2026-09-02 under a Rule 10b5-1 trading plan.
StockNASDAQ · US · USDHealthcare · Health Information Services
$WAY
Waystar Holding Corp.
Price · $WAYvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $WAY in the last 7 days.
Insider · 30dAll trades →
- Buys
- — 0 txs
- Sells
- $4.2M 3 txs
Hawkins Matthew J.3× · $4.2M
10b5-1 share of filings100%
Top stories · $WAYMore →
AUG 26·prnewswire.com
Waystar Launches New Agentic Solutions Transforming AI Into Action Across the Revenue Cycle
Waystar (Nasdaq: WAY) launched new AI-driven agentic capabilities to autonomously execute revenue cycle workflows. Features include autonomous claim resolution, conversational analytics, and patient financial engagement. The company aims to reduce administrative work and improve financial outcomes for healthcare providers.
AUG 26·yahoo.com
Waystar Targets Autonomous Revenue Cycle With AI, Automation Push at Investor Day
Waystar (NASDAQ:WAY) outlined its AI and automation strategy at its Investor Day, highlighting plans for new products and monetization paths. The company aims for low-double-digit revenue growth and adjusted EBITDA margins above 40%. Waystar also announced new executive hires and reported net leverage of 2.5 times, with plans to reduce debt.
WAY sentiment & insider activity
Recent WAY coverage spans earnings, insider activity and technology.
In the last 30 days, WAY insiders filed 3 SEC Form 4 transactions — no purchases and 3 sales ($4.2M). The most active reporter was Hawkins Matthew J., Chief Executive Officer, with 3 filings. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
What's driving WAY
This is a routine 10b5-1 insider sale disclosure, not a fundamental update, but it can still affect near-term sentiment and positioning.
First disclosure of Waystar's AltitudeAI product suite.
Potential revenue uplift from AI automation and new premium services; modest near‑term price impact.
Insider selling by the CEO is a near-term sentiment datapoint, but the presence of a pre-arranged 10b5-1 plan reduces signal strength.
Management emphasizes accelerating platform consolidation, cross-sell (Iodine), and incremental revenue expectations from expanded client implementations.
alphai scores every news story that mentions WAY with an AI model for sentiment and relevance, and aggregates insider trades from Waystar Holding Corp.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $WAY
Score
Hawkins Matthew J. sold $2.1M of WAY
Hawkins Matthew J. (Chief Executive Officer) sold 82,500 shares of Waystar Holding Corp. (WAY) at $25.97 ($2.14M total) on 2026-09-02 under a Rule 10b5-1 trading plan.
2 min readWaystar Launches New Agentic Solutions Transforming AI Into Action Across the Revenue Cycle
Waystar (Nasdaq: WAY) launched new AI-driven agentic capabilities to autonomously execute revenue cycle workflows. Features include autonomous claim resolution, conversational analytics, and patient financial engagement. The company aims to reduce administrative work and improve financial outcomes for healthcare providers.
3 min read
Waystar Targets Autonomous Revenue Cycle With AI, Automation Push at Investor Day
Waystar (NASDAQ:WAY) outlined its AI and automation strategy at its Investor Day, highlighting plans for new products and monetization paths. The company aims for low-double-digit revenue growth and adjusted EBITDA margins above 40%. Waystar also announced new executive hires and reported net leverage of 2.5 times, with plans to reduce debt.
3 min readHawkins Matthew J. sold $2.1M of WAY
Hawkins Matthew J. (Chief Executive Officer) sold 82,500 shares of Waystar Holding Corp. (WAY) at an average of $25.02 ($25.01–$25.04, $2.06M total) across 2 trades over 2026-08-11 to 2026-08-13 under a Rule 10b5-1 trading plan.
2 min readWaystar (WAY) Q2 2026 Earnings Call Transcript
Waystar (WAY) reported Q2 2026 demand for its revenue cycle platform, citing client expansion and platform consolidation. Clients over $100k trailing revenue rose 15% to 1,453, with net revenue retention of 108%. The company cited $1M-plus ACV bookings, including ProMedica’s nearly $10M in billing opportunities and other incremental revenue claims.
7 min readIs Waystar Holding (WAY) Undervalued Following Strong Q2 Results And Higher Guidance?
Simply Wall St reports Waystar Holding (WAY) posted strong Q2 2026 results and raised its full-year revenue outlook, citing AI-driven solutions and cross-sell activity after its Iodine Software acquisition. The article notes the stock at $21.11, down 32.71% YTD and 40.69% over 1 year, with fair value estimates of $33.83 (and $45.32 via DCF).
7 min readWaystar (WAY) Stock Price Reset Follows Margin Strength And Slower Organic Growth
United States / Healthtech / NasdaqGS:WAY Waystar (WAY) Stock Price Reset Follows Margin Strength And Slower Organic Growth July 31, 2026 Waystar Holding stock just absorbed a 14.6% hit in a single session, even though the earnings story centered on expanding profitability rather than a crack in the business model. Coming into the print, shares had been roughly flat over three months. This framed today’s selloff as a sharp reset, not the end of a long slide.
6 min readWaystar Holding Corp. (WAY): Results of Operations and Financial Condition
Waystar Holding Corp. (WAY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Waystar Reports Second Quarter 2026 Results Q2 revenue of $319.7M, up 18% YoY Q2 net income of $40.9M and non-GAAP net income of $83.3M Q2 net income margin of 13%; adjusted EBITDA margin of 43% Raising revenue and adjusted EBITDA guidance for 2026 LEHI, Utah and LOUISVILLE, Ky.,
4 min read
Waystar Earns Overall "A" Rating from KLAS for Revenue Cycle Suites, Cementing Its Platform Advantage in a Fragmented Market
Waystar (Nasdaq: WAY) said KLAS Research’s inaugural Revenue Cycle Management Suites 2026 report gave it an overall “A” satisfaction rating. KLAS surveyed “deep adopters” using at least three RCM solutions from one vendor and found 76%–100% of Waystar clients reported lower cost-to-collect and improved collections. Waystar cited integrated platform benefits.
3 min readFitch upgrades Waystar rating on lower leverage expectations By Investing.com
Fitch Ratings upgraded Waystar Holding Corp. (NYSE:WAY) and Waystar Technologies’ Long-Term Issuer Default Rating to BB+ from BB, and raised the first lien term loan to BBB- (Recovery Rating RR2). Fitch cited lower leverage expectations, with Fitch-adjusted EBITDA leverage projected below 3.0x in fiscal 2026 and sustained under 3x, plus strong recurring revenue and FCF.
3 min read